TCIM
CALA

TIAA CREF Investment Management’s Calithera Biosciences, Inc CALA Stock Holding History

TIAA CREF Investment Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.28M Buy
9,525
+5,043
+113% +$530K ﹤0.01% 2208
2018
Q4 		$359K Buy
4,482
+602
+16% +$59.4K ﹤0.01% 2708
2018
Q3 		$407K Sell
3,880
-1,765
-31% -$168K ﹤0.01% 2800
2018
Q2 		$564K Sell
5,645
-773
-12% -$87.6K ﹤0.01% 2737
2018
Q1 		$809K Sell
6,418
-4,265
-40% -$665K ﹤0.01% 2534
2017
Q4 		$1.78M Buy
10,683
+1,227
+13% +$314K ﹤0.01% 2196
2017
Q3 		$2.98M Buy
9,456
+275
+3% +$86.7K ﹤0.01% 1928
2017
Q2 		$2.73M Buy
+9,181
New +$2.46M ﹤0.01% 1983
2016
Q2 		– Sell
-1,953
Closed -$222K – 3209
2016
Q1 		$222K Hold
1,953
– – ﹤0.01% 2968
2015
Q4 		$299K Hold
1,953
– – ﹤0.01% 3015
2015
Q3 		$212K Hold
1,953
– – ﹤0.01% 3035
2015
Q2 		$279K Buy
1,953
+1,202
+160% +$279K ﹤0.01% 3079
2015
Q1 		$247K Hold
751
– – ﹤0.01% 3038
2014
Q4 		$303K Buy
+751
New +$196K ﹤0.01% 3057

Other funds holding CALA

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TIAA CREF Investment Management's CALA Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Calithera Biosciences, Inc (CALA) stake by 113% in Q1 2019, buying an estimated $530K and bringing the position to 9,525 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2208.

TIAA CREF Investment Management first reported a position in CALA in Q4 2014 and has held it in 14 quarters since. The position peaked at $2.98M in Q3 2017. 71 funds tracked by Wall St. Rank hold CALA as of Q1 2019.

  • TIAA CREF Investment Management held 9,525 shares of Calithera Biosciences, Inc worth $1.28M as of Q1 2019.
  • TIAA CREF Investment Management bought 5,043 Calithera Biosciences, Inc shares in Q1 2019, an estimated $530K.
  • Calithera Biosciences, Inc made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2208 holding.
  • TIAA CREF Investment Management first reported a position in Calithera Biosciences, Inc in Q4 2014 and has held it in 14 quarters since.
  • TIAA CREF Investment Management's Calithera Biosciences, Inc position peaked at $2.98M in Q3 2017.
  • 71 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.